But a validated clinical diagnostic test does not yet exist
Myth 1: Semaglutide Directly Changes Potassium Levels One common myth is that semaglutide itself directly changes potassium levels
This should include: Comprehensive medication review : Documenting all prescribed medications, over-the-counter products, and supplements to identify potential interactions, particularly noting fluoxetine's strong CYP2D6 inhibition Mental health evaluation : Assessing depression severity, suicide risk, and treatment response to fluoxetine Weight and metabolic parameters : Recording baseline weight, BMI, waist circumference, blood pressure, and relevant blood tests (HbA1c, lipid profile, liver function) Renal function and electrolytes : Particularly sodium levels, given the risk of SSRI-induced hyponatraemia Cardiovascular assessment : Particularly important given semaglutide's potential effects on heart rate Gastrointestinal and gallbladder history : Identifying pre-existing conditions that might be exacerbated Ophthalmological assessment : For patients with diabetes, as rapid improvement in glycaemic control may worsen diabetic retinopathy Ongoing monitoring should occur at regular intervals, typically: Monthly initially : During Wegovy dose escalation (following the standard titration schedule from 0.25 mg to 2.4 mg over 1620 weeks) Every 36 months : Once stable doses are achieved, monitoring weight, mental health status, side effects, and treatment adherence As clinically indicated : More frequent review if concerns arise Dose adjustments may be necessary based on individual response
Medications and other Remedies for Constipation: Colace-OTC stool softener Dulcolax laxative OTC Senna OTC Magnesium can sometimes be helpful Lactulose (prescription) Linaclotide (prescription) Lubiprostone (prescription) Dietary modifications for constipation: Eating smaller, more frequent meals and avoiding high-fat foods can help minimize gastrointestinal discomfort
